Key regions: China, Europe, Australia, United States, Germany
The pharmaceutical industry in Bhutan has been growing rapidly in recent years, with a particular focus on the Other Pharmaceuticals market. This market includes a wide range of products, such as vitamins, minerals, and supplements, and is driven by a variety of factors.
Customer preferences: One of the key drivers of growth in the Other Pharmaceuticals market in Bhutan is changing customer preferences. Consumers are becoming more health-conscious and are increasingly interested in natural and alternative remedies. This has led to a growing demand for products such as herbal supplements and traditional medicines, which are seen as safer and more effective than synthetic drugs.
Trends in the market: Another trend driving growth in the Other Pharmaceuticals market in Bhutan is the rise of e-commerce. Online shopping has become increasingly popular in the country, particularly among younger consumers who are more likely to purchase health and wellness products online. This has led to the emergence of a number of online retailers specializing in natural and alternative remedies, which has further fueled growth in the market.
Local special circumstances: Bhutan's unique cultural and environmental factors have also played a role in the development of the Other Pharmaceuticals market. The country is known for its rich biodiversity and traditional medicine practices, which have been passed down through generations. Many of these remedies are now being commercialized and sold as supplements and other products, both domestically and internationally.
Underlying macroeconomic factors: Finally, macroeconomic factors such as rising disposable incomes and an aging population have also contributed to the growth of the Other Pharmaceuticals market in Bhutan. As more people are able to afford health and wellness products, demand for supplements and other remedies is likely to continue to rise. Additionally, as the population ages, there is expected to be an increased focus on preventative healthcare and natural remedies, further fueling growth in the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
